MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, M. K.C.
Right arrow Articles by Wong, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, M. K.C.
Right arrow Articles by Wong, Y. H.

Vol. 58, Issue 5, 993-1000, November 2000


The Amino Terminus of Galpha z is Required for Receptor Recognition, Whereas its alpha 4/beta 6 Loop Is Essential for Inhibition of Adenylyl Cyclase

Maurice K.C. Ho and Yung H. Wong

Department of Biochemistry and Biotechnology Research Institute, Hong Kong University of Science and Technology, Hong Kong, China

    Abstract
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Gz couples to most of the known Gi-linked receptors and its alpha  subunit (Galpha z) inhibits adenylyl cyclases as efficiently as Galpha i subtypes. A series of chimeric Galpha subunits with different portions of Galpha z and Galpha t1 (a regulator of cGMP phosphodiesterase) were constructed to study the essential structural elements of Galpha z that determine receptor coupling and effector interaction. The receptor-mediated functions of the chimeras were assessed in two aspects: 1) stimulation of type 2 adenylyl cyclase through the release of beta gamma subunits from the chimeras, and 2) inhibition of isoproterenol-stimulated adenylyl cyclase by the chimeric Galpha subunits. The results suggested that the presence of both termini of Galpha z were critical for coupling to delta -opioid receptor, with the N-terminal region being more important. Moreover, a stretch of amino acids (295-319) corresponding to the alpha 4/beta 6 loop was identified as one of the adenylyl cyclase inhibitory domains of Galpha z.

    Introduction
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

The signaling properties of alpha  subunit of Gz protein (Galpha z) are very similar to the three Galpha i subtypes. All G protein-coupled receptors that have been shown to interact with Gz are known couplers of Gi proteins (Fields and Casey, 1997; Ho and Wong, 1998). Although the overall amino acid identity of Galpha z and Galpha i2 is about 60%, they inhibit adenylyl cyclase (AC) in a similar fashion (Wong et al., 1992; Kozasa and Gilman, 1995). The sequence identities are even higher when only their C-terminal halves are compared, where the putative receptor- and effector-interacting domains were located. However, subtle differences are found between the amino acid sequences of Galpha i2 and Galpha z, which suggest that they may use different structural elements to achieve similar functions. Incorporation of the last five residues of either Galpha i2 or Galpha z, which shared very low homology to each other, to the corresponding region of Galpha q broadened its receptor coupling profile to both Gq- and Gi-linked receptors (Conklin et al., 1993). However, the replacement of the last 36 amino acids of Galpha z with those of Galpha t1 did not block the coupling of the resultant Galpha z/Galpha t1 to Gi-linked receptors (Tsu et al., 1997). Indeed, a number of studies suggested that the amino terminus of Galpha subunit might be crucial for receptor coupling (Hamm et al., 1988; Kostenis et al., 1997). Furthermore, a stretch of amino acids, 220 to 240 of Galpha 16, has been shown to be essential for receptor coupling (Lee et al., 1995). It prompted us to identify the essential determinants of Galpha z for specifying its receptor coupling property.

The effector interacting domains of various Galpha subunits are generally localized at the C-terminal half of the amino acid sequence (Berlot and Bourne, 1992; Medina et al., 1996; Grishina and Berlot, 1997). Although Galpha s and Galpha i2 regulate AC in opposite fashions, they have evolved similar and different stretches of amino acids for effector interactions (Berlot and Bourne, 1992; Grishina and Berlot, 1997). The AC inhibiting residues of Galpha i2 were localized at the Switch II region (similar to Galpha s) and alpha 4/beta 6 loop (unlike Galpha s) by alanine mutagenesis (Grishina and Berlot, 1997). It is unclear if regions similar to those found in Galpha i2 are responsible for effector interaction in Galpha z. Interestingly, mutations of the acylation-modified N-terminal residues altered the constitutive inhibitory action of Galpha z to AC (Wilson and Bourne, 1995). Moreover, alanine substitution of the protein kinase C-phosphorylation sites of mutationally active Galpha z attenuated its inhibitory effect on AC (Ho and Wong, 1997). It is still possible that the N-terminus of Galpha z is also involved in effector regulation.

We attempted to localize the receptor interacting as well as AC inhibiting domains of Galpha z by constructing chimeric Galpha subunits using Galpha z and Galpha t1. Galpha t1 is approximately 60% identical with Galpha z; hence, their tertiary structures should have considerable resemblance. Within the Galpha i-subfamily, Galpha t1 is primarily coupled to rhodopsin and regulates cGMP phosphodiesterase. Introduction of Galpha t1 portions into a Galpha z backbone would be expected to have minimal interference on the protein folding and AC inhibition. Desired recombinant proteins were transiently expressed in human embryonic kidney (HEK) 293 cells and the functions of the chimeras were assessed in two aspects. To study the receptor coupling events, the abilities of chimeric Galpha subunits to couple to delta -opioid receptor (DOR) were monitored by the beta gamma -mediated stimulation of type 2 adenylyl cyclase (AC2). For studying the effector interaction, the abilities of the chimeras to inhibit isoproterenol-stimulated cAMP accumulation upon the activation of DOR were monitored. Another series of chimeras were constructed with a point mutation that rendered GTPase-deficient phenotypes (Freissmuth and Gilman, 1989; Graziano and Gilman, 1989). They were applied to investigate the constitutively inhibitory effects of the chimeras on isoproterenol-stimulated AC activity.

    Experimental Procedures
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Materials. AC2 and DOR cDNA were gifts from Randall Reed (Johns Hopkins School of Medicine, Baltimore, MD) and Christopher Evans (University of California, Los Angeles, CA), respectively. Pertussis toxin (PTX) was purchased from List Biological Laboratories, Inc. (Campbell, CA). HEK 293 cells were obtained from the American Type Culture Collection (Rockville, MD). [d-Pen2,5]enkephalin (DPDPE) was from Research Biochemicals Inc. (Natick, MA). Antisera against Galpha z and Galpha t1 were from Gramsch Laboratories (Schwabhausen, Germany) and Transduction Laboratories (Lexington, KY), respectively. [3H]Adenine was purchased from Amersham (Buckinghamshire, UK). Plasmid purification columns were obtained from Qiagen (Hilden, Germany). Taq DNA polymerase, customized primers, restriction endonucleases, and cell culture reagents were obtained from Life Technologies Inc. (Grand Island, NY). All other chemicals were purchased from Sigma (St. Louis, MO).

Construction of Chimeric alpha  Subunits. A complete list of chimeric and mutational Galpha subunits is shown in Table 1. The chimeras zt40 and zt43 were constructed by polymerase chain reaction (PCR) using a pair of chimeric primers (Table 2). The full-length PCR product was sequenced using Sequenase Version 2.0 DNA sequencing kit from Amersham. Other chimeras were constructed by making use of convenient unique restriction sites and exchanging the corresponding restriction fragments of Galpha t1, zt40, or zt43 with Galpha z (Table 1). For example, the junctional restriction sites of tz36, tz60, and tz143 are BglII, AflIII, and BamHI, respectively. The insertion mutant +4t and PTX-resistant Galpha t1CG mutant were made by PCR using Galpha t1 as the template, and +4t/CG is generated by combining +4t and Galpha t1CG together through restriction cutting. -4z Is derived from Galpha z with the residues 11 to 14 deleted. For si143 and sz143, the portion of Galpha s was obtained by partial digestion with BamHI and then ligation with the C-terminal portion of either Galpha i2 or Galpha z. GTPase-deficient mutants of various chimeras were made by replacing Galpha t1 and Galpha z with Galpha t1RC (Ho et al., 1999) and Galpha zQL (Wong et al. 1992), respectively in the construction procedures. All the cDNA constructs were subcloned in the mammalian expression vector pcDNAI at EcoRI site.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
List of mutational and chimeric Galpha subunits

Except for the last three constructs, the nomenclatures of the chimeras are according to the parental Galpha subunits (templates) and the numbers of amino acids of Galpha z present in the chimeras. All chimeras are constructed either by PCR using the primers listed in Table 2 or by restriction digestion (RD) of templates and subsequent ligation. The restriction sites shown are the junctional sites of the ligated fragments.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
List of primers

Transfection of HEK 293 Cells and cAMP Accumulation Assay. HEK 293 cells were cultured with Eagle's minimal essential medium (MEM) supplemented with 10% fetal calf serum (v/v), 50 U/ml penicillin, and 50 µg/ml streptomycin at 37°C in humidified air with 5% CO2. They were cotransfected with various recombinant DNA constructs using DEAE-dextran/chloroquine method as described previously (Wong, 1994). Transfected cells were labeled with 1 µCi/ml of [3H]adenine in MEM with 1% fetal calf serum and treated with 100 ng/ml PTX as appropriate. Labeled cells were treated with proper receptor agonists in 20 mM HEPES-buffered MEM with 1 mM 1-methyl-3-isobutylxanthine for 30 min and the reactions were terminated by adding ice-cold 5% trichloroacetic acid with 1 mM ATP. Separation of labeled cAMP from other nucleotides was achieved by sequential ion exchange chromatography as described previously (Salomon, 1991). The cAMP levels were interpreted as the ratios of the counts per minute of [3H]cAMP fractions to those of [3H]ATP fractions and expressed as [cAMP/(cAMP + Total) × 1000]. Absolute values for cAMP accumulation varied between experiments, but variability within a given set of transfection was in general <10%. Data shown in the figures were the mean ± S.E.M. of three to five individual experiments performed in triplicate. ANOVA and paired t test with 95% confidence was used to analyze the significance between different treatment groups.

Western Blotting Analysis. Crude membrane proteins from HEK 293 cells transfected with various chimeric Galpha subunits were extracted as described previously (Ho and Wong, 1997). Each protein sample (50 µg) was resolved in 10% SDS-polyacrylamide gel and transferred to polyvinylidene fluoride membrane. Antiserum 3A-170 (Gramsch Laboratories, Schwabhausen, Germany) against the carboxyl terminus of Galpha z was used for the detection of Galpha z, tz, and ztz chimeras, whereas Galpha t1, zt40, and zt43 were identified with anti-Galpha t1 antiserum (Transduction Laboratories).

    Results
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

The Role of the C-Terminus of Galpha z in Coupling with DOR. The abilities of chimeric Galpha subunits to couple to DOR were monitored by the beta gamma -mediated stimulation of AC2. This reporter system is advantageous because it could be generally applied to assess the coupling between different categories of receptor-G protein pairs without considering the functions of the Galpha subunits. Moreover, AC2 is relatively insensitive to Galpha i-mediated inhibition (Taussig et al., 1994). It eliminates the possibility that Galpha z and beta gamma complex act on AC2 in an antagonistic fashion. The AC2 system is especially useful for checking the receptor coupling efficiencies of particular chimeric Galpha subunits that have lost the integrity of effector interacting domains. A schematic representation of the first series of chimeric Galpha subunits was shown in Fig. 1A. We attempted to examine the importance of the C-terminal tail of Galpha z on receptor coupling using this series of chimeras. In the vector control, HEK 293 cells expressing Galpha sQL, DOR, and AC2 were treated with or without PTX. Addition of 100 nM DPDPE stimulated the cAMP production to about two times the basal level in the absence of PTX treatment (Fig. 1B). The DPDPE-induced enhancement was abolished in cells treated with PTX, indicating that the coupling between DOR and the endogenous Gi proteins was obstructed. Coexpression of recombinant Galpha z provided a larger pool of G protein trimers capable of coupling to DOR; hence, in the absence of PTX treatment, a 150% enhancement of the cAMP production was observed compared with the corresponding response in vector control. PTX treatment partially reduced the cAMP level of Galpha z-expressing cells, which suggested that Gz could functionally replace the role of endogenous Gi and mediated the DPDPE-induced cAMP production in a PTX-resistant manner. In the case of Galpha t1, the response in the absence of PTX treatment was significantly lower than that of vector control and was close to the basal value. Suppression of beta gamma -mediated AC2 activity was caused by the strong beta gamma -scavenging property of Galpha t1. Moreover, there was no increase of cAMP level in cells treated with PTX, which inactivated endogenous Gi and the recombinant Gt1. These results are consistent with those reported earlier (Tsu et al., 1997).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   The first series of chimeric Galpha subunits and receptor-mediated regulation of AC2. The parental (Galpha z and Galpha t1) and chimeric Galpha subunits are diagrammatically shown in A. B, mutationally active Galpha sQL (0.025 µg/ml), AC2 (0.25 µg/ml), DOR (0.25 µg/ml), and 0.25 µg/ml of one of the Galpha subunits in A were coexpressed in HEK 293 cells. Transfected cells were treated with or without 100 ng/ml PTX as indicated. cAMP levels were measured in the absence or presence of 100 nM DPDPE. Asterisks indicate the DPDPE-induced cAMP levels are significantly higher than those of vector control.

One of our recent studies showed that the Galpha z/Galpha t1 and Galpha z/Galpha i2 chimeras containing the last 36 amino acids of Galpha t1 and Galpha i2, respectively, can couple to DOR efficiently (Tsu et al., 1997). To determine whether the N-terminus is required for receptor coupling, a reversed chimera tz36, an Galpha t1 subunit with the C-terminal 36 residues of Galpha z (Fig. 1A, the third construct), was constructed and examined for its ability to couple to DOR. In this assay system, tz36 did not release beta gamma subunits for stimulating AC2 upon DOR activation (Fig. 1B). Subsequent substitution of larger C-terminal portions of Galpha t1 with Galpha z sequence up to 143 amino acids (tz60 and tz143) also did not rescue the coupling to DOR. Two other chimeras sz143 and si143 (Fig. 1A, the sixth and seventh constructs) were constructed by replacing the C-terminal tail of Galpha s with that of Galpha z or Galpha i2 portions. These two chimeras resembled tz143 and did not release beta gamma complex for AC2 stimulation upon DOR activation. These results further suggested neither the C-terminal 143 amino acids of Galpha i2 nor Galpha z could rescue the receptor coupling and the loss of function of tz143, sz143, and si143 may not be related to the choice of parental Galpha subunits for chimera construction. Obviously, other essential receptor interacting regions were located on the N-terminal half of Galpha z sequence.

The last three chimeras of this series were constructed as mirror images of tz36, tz60, and tz143. The chimeras were denoted as zt319, zt295, and zt212, respectively (Fig. 1A, the eighth to tenth constructs; numbers refer to the last amino acid of Galpha z). Replacement of the C-terminal tail of Galpha z with that of Galpha t1 may alter its coupling to DOR. However, all three zt chimeras seemed to couple to DOR and showed substantial increases of cAMP accumulation in the absence of PTX treatment (enhanced by 60, 50, and 65% for zt319, zt295, and zt212, respectively; see Fig. 1B). These results further reinforced the idea that the C-terminal 143 amino acids of Galpha z are sufficient for receptor recognition and some critical structural elements are located on the N-terminal half of Galpha z. Because these zt chimeras acquired the C-terminal tail of Galpha t1, they should be sensitive to PTX-mediated inactivation. Accordingly, there was no increment of cAMP levels in all three cases when the cells were pretreated with PTX (Fig. 1B).

The N-Terminus of alpha z Is Essential for Receptor Coupling. Recent studies highlighted the importance of the N-terminus of Galpha subunit for receptor specificity (Kostenis et al., 1997). A second series of chimeras were thus constructed to verify the role of the N-terminus of Galpha z on DOR coupling. The chimera zt40 was constructed so that the N-terminal helix became Galpha z-like (Fig. 2A, the third construct). In the absence of PTX, DPDPE-induced enhancement of cAMP accumulation in zt40-transfected cells resembled that of Galpha z-transfected cells. However, zt40 is PTX-sensitive because it acquired the C-terminus of Galpha t1 and the DPDPE-induced cAMP production was abolished in the presence of PTX (Fig. 2B). This result suggested that the N-terminal region of Galpha z was an essential determinant for receptor coupling. The chimera ztz40/36 was then constructed based on zt40 and tz36 (Fig. 2A, the fourth construct) to check whether the inclusion of the Galpha z-specific C-terminus would confer PTX resistance to the ztz40/36 chimera. The phenotype of ztz40/36 was more or less the same as Galpha z, except that the percentage response over basal value was slightly lower than that of Galpha z (Fig. 2B). It suggested that the C-terminus of Galpha z only conferred PTX-resistance but did not further enhance the receptor coupling efficiency. Two other ztz chimeras, ztz40/60 and ztz40/143 (Fig. 2A, sixth and seventh constructs), were also able to couple to DOR and stimulate AC2 to slightly greater degree than ztz40/36 (Fig. 2B).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 2.   The second series of chimeric Galpha subunits and receptor-mediated regulation of ACs. The parental (Galpha z and Galpha t1) and chimeric Galpha subunits are diagrammatically shown in A. B, HEK 293 cells were transfected, labeled, and treated as indicated in the legend to Fig. 1B. Basal cAMP levels ranged from 4.11 ± 0.33 to 6.72 ± 0.18. Single and double asterisks indicate that the basal and DPDPE-induced cAMP levels, respectively, are significantly higher than those of vector control. C, HEK 293 cells were cotransfected with beta 2AR (0.15 µg/ml), DOR (0.025 µg/ml), and 0.25 µg/ml of one of the Galpha subunits in A. Transfected cells were all treated with 100 ng/ml PTX. cAMP production was triggered by treating the cells with 10 µM isoproterenol alone or in the presence of 100 nM DPDPE. DPDPE-induced inhibition was expressed as percentage inhibition of the isoproterenol-stimulated cAMP levels that ranged from 10.55 ± 1.78 to 14.08 ± 1.24. Asterisks indicate the DPDPE-induced inhibition of cAMP production is significantly greater than that of vector control.

Galpha z has distinct biochemical properties in that the loading and hydrolysis of GTP by Galpha z are much slower than other Galpha subunits (Casey et al., 1990). The main reason is correlated to the variance of sequence identity in the G-1 GTP-binding region (amino acids 41-43). It is unknown whether the triplet variations affect the receptor coupling efficacies of the chimeras. zt43 and the corresponding series of ztz chimeras (ztz43/36, ztz43/60, and ztz43/143) were made so that the G-1 region resembled the Galpha z sequence (Fig. 2A, the seven to tenth constructs). However, the profile of responses was similar to the zt40 series. All three ztz chimeras with N-terminal 43 residues of Galpha z but not zt43 coupled to DOR and stimulated AC2 in the presence of PTX (Fig. 2B). The results eliminated the assumption that the variation of the G-1 GTP-binding region of Galpha z affected the receptor interaction and subsequent release of beta gamma subunits.

The Amino Acids 11 to 14 of alpha z Are Essential for Receptor Coupling. The N-terminus of Galpha t1 is considerably divergent from those of Galpha i2 and Galpha z in two aspects. First, the N-terminus of Galpha z is more homologous to Galpha i2 (47.1%) than to Galpha t1 (33.3%). Second, the length of the theoretical N-terminal helix of Galpha t1 is shorter than Galpha i2 or Galpha z by four amino acids (Fig. 3A). Progressive deletion of the six N-terminal residues of Galpha q broadened its receptor coupling specificity (Kostenis et al., 1997). It is conceivable that the length of the N-terminal region of the chimeras may affect receptor activation. In the case of zt40, its ability to couple to DOR may be attributable to the elongation of its N-terminal region. To test this possibility, an insertion mutant of Galpha t1 was constructed by inserting the four residues of Galpha z between residues 10 and 11 of Galpha t1. The cysteine residue at -4 position of the C-terminus of Galpha t1 was mutated into glycine and the Galpha t1 mutant (termed +4t/CG) became resistant to PTX-mediated inactivation. This mutation allowed us to examine the coupling of +4t/CG with DOR without the interference caused by endogenous Gi proteins. In the presence of PTX, application of DPDPE can induce a modest increase of cAMP level in +4t/CG-transfected cells, which is significantly higher than that of Galpha t1CG- or vector-transfected cells (Fig. 3B). It indicated that +4t/CG can indeed couple to DOR in a PTX-insensitive manner although the response is relatively weak (~40% increase as compared with the basal). To further confirm the role of these four amino acids, a deletion mutant of Galpha z was constructed with the amino acids 11 to 14 removed (termed -4z) and the mutant was tested for its ability to recognize DOR. In AC2 assays, -4z-transfected cells showed only slight reduction of DPDPE-induced cAMP accumulation compared with Galpha z (Fig. 3B). The reduction of response was also observed when the cells were pretreated with PTX. It suggested that residues 11 to 14 of Galpha z form one of the minor determinants for DOR coupling. The reduction of DOR-induced inhibitory response in -4z-transfected cells is probably independent to its expression level (Fig. 4) and effector interaction. A constitutively active mutant of -4z, -4z/QL, inhibited isoproterenol-induced cAMP production in the cells cotransfected with beta 2-adrenoceptor to a similar extent as Galpha zQL (Fig. 3C). Overall, these results strongly suggested that the N-terminal residues 11 to 14 of Galpha z are involved in receptor recognition.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   Amino acids 11 to 14 of Galpha z are essential for DOR coupling. A, the sequences of the two termini of Galpha z, Galpha t1, and three mutants were aligned. Deletion of the residues 11 to 14 of Galpha z yielded the mutant -4z. A cysteine-to-glycine mutation was introduced to the -4 position of Galpha t1 to form Galpha t1CG. +4t/CG was made by inserting the residues 11 to 14 of Galpha z between residues 10 and 11 of Galpha t1CG. Underlined residues are the mutated and inserted residues. B, HEK 293 cells were transfected, labeled, and treated as indicated in the legend to Fig. 1B. Basal cAMP levels ranged from 4.51 ± 0.73 to 5.45 ± 0.44. Single and double asterisks indicate that the basal and DPDPE-induced cAMP levels, respectively, are significantly higher than those of vector control. C, HEK 293 cells were cotransfected with 0.15 µg/ml of beta 2AR and 0.25 µg/ml of one of the Galpha subunits. cAMP production was triggered by treating the cells with 10 µM isoproterenol. The cAMP levels were expressed as percentage responses of Galpha z. WT, wild type; QL, active mutant.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4.   Western blotting analysis of chimeric Galpha subunits. 0.25 µg/ml of each chimeric Galpha subunit cDNA was transfected into HEK 293 cells and membrane proteins were extracted for immunodetection. Antisera specific against Galpha t1 and Galpha z were applied for blots in A and B, respectively. Two individual experiments using different batches of protein samples showed similar results.

Protein Expression of Chimeric Galpha Subunits. Membrane proteins of the cells transfected with various chimeras studied here were separated by denaturing gel electrophoresis and the chimeras were detected by specific antisera. The expression levels of zt40 and zt43 were similar to tz36, but lower than Galpha t1 in HEK 293 cells as detected by an anti-Galpha t1 antiserum (Fig. 4A). Both Galpha t1CG and +4t/CG were expressed strongly in HEK 293 cells. Detection with an antiserum against the last 15 residues of Galpha z facilitated direct comparison of the expression levels of various chimeras (Fig. 4B). All chimeric alpha  subunits were expressed to similar levels in HEK 293 cells as Galpha z. The results indicated that most of the chimeras studied here are expressed to similar levels.

Receptor-Mediated Inhibition of AC by Chimeric alpha  Subunits. Some of the chimeras contained increasing lengths of C-terminal tails of Galpha z, and could serve as useful tools for localizing the AC-inhibiting regions on Galpha z. Thus, we tested these chimeras for their ability to inhibit AC. HEK 293 cells transfected with beta 2-adrenoceptor, DOR, and a parental or chimeric Galpha subunit were pretreated with PTX and then stimulated with 10 µM isoproterenol to elevate the intracellular cAMP level. Coadministration of DPDPE to the cells expressing Galpha z showed about 30 to 40% reduction of isoproterenol-induced cAMP level, which was not observed in the cases of vector control or Galpha t1-transfected cells (Fig. 2C). Both zt40 and zt43-transfected cells lacked DPDPE-induced inhibition of AC activity. The N-terminal Galpha z-specific sequence of these two chimeras did not contain sufficient structural elements for AC inhibition. Next, we examined the six ztz chimeras, because it has been shown that the N-terminal region of Galpha z was important for the coupling to DOR. ztz40/36 and ztz43/36 showed no significant inhibitory effect on the cAMP levels (Fig. 2C). Chimeras containing 60 or more C-terminal amino acids of Galpha z inhibited AC significantly. Such results indicated that one of the essential AC inhibitory domains must be located within amino acids 296 to 319 of Galpha z.

Inhibition of AC by Constitutively Active Chimeric Galpha Subunits. Introduction of a point mutation at the GTP-binding regions of Galpha subunit created receptor-independent constitutively active mutants (Freissmuth and Gilman, 1989; Graziano and Gilman, 1989). This approach has been successfully applied for studying the effector interacting domains of various Galpha subunits even when the receptor interacting domains were disrupted in the chimeras (Medina et al., 1996; Grishina and Berlot, 1997). For the constructs used in this study, Arg-174 of the Galpha t1 domain and Gln-205 of the Galpha z portion were mutated to cysteine and leucine, respectively, and these chimeras were used to examine the receptor-independent constitutive inhibition of AC activity. Results are summarized in Fig. 5. As a positive control, the Galpha z mutant Galpha zQL (Wong et al., 1992) inhibited isoproterenol-stimulated cAMP level by 40 to 50% compared with the vector control, whereas Galpha t1 exhibited no observable inhibition on the AC activity. Among the three tz chimeras, tz60(RC) and tz143(RC) inhibited AC significantly, albeit to a lesser extent than that of Galpha zQL. Among the three zt chimeras, only zt319(QL) inhibited AC efficiently. Of the six ztz chimeras, only four---ztz40/60(RC), ztz40/143(RC), ztz43/60(RC), and ztz43/143(RC)---were able to inhibit AC significantly. The degrees of inhibition for all these chimeras were comparable with each other but slightly weaker than Galpha zQL. The protein expression levels of all these constitutively active chimeras were similar to each other and also comparable with those of their wild-type counterparts (Fig. 4). Collectively, the results confirmed the essential role of amino acids 295 to 319 of Galpha z for AC inhibition because all chimeras that possess the ability to inhibit AC contained this stretch of residues from Galpha z.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Constitutive inhibition of AC by mutationally active chimeric Galpha subunits. HEK 293 cells were cotransfected with 0.15 µg/ml of beta 2AR and 0.25 µg/ml of one of the Galpha subunits. cAMP production was triggered by treating the cells with 10 µM isoproterenol. The cAMP levels of the chimera-transfected cells were expressed as percentage inhibition of the mean value of the isoproterenol-stimulated cAMP levels of the vector control. Asterisks indicate the cAMP levels are significantly greater than the vector control.

    Discussion
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Gz is not simply a PTX-resistant substitute of the three Gi subtypes but it may be involved in a number of novel signaling events. The specific functional interactions of Galpha z with newly discovered proteins such as RGSZ1 (Glick et al., 1998), Rap1GAP (Meng et al., 1999), and GRIN1 (Chen et al., 1999) suggested that Galpha z has its distinct roles in signal transduction in addition to the regulation of ACs. Localization of the functional domains of Galpha z could provide valuable information for a better understanding of the roles of Galpha z in different molecular events. The present study investigated the receptor and AC-interacting domains of Galpha z. Two major findings could be concluded. First, the N-terminal sequence of Galpha z seemed to be a critical determinant for the coupling to DOR. Second, one of the AC inhibiting domains of Galpha z is located at amino acids 296-319.

A series of chimera studies indicated that the last five amino acids of Galpha subunits are essential for determining the receptor specificity (Conklin et al., 1993, 1996). The last five amino acids of Galpha t1 are identical with those of Galpha i2 (Fig. 6), yet Galpha t1 primarily couples to rhodopsin. Both an evolutionary trace analysis (Lichtarge et al., 1996) and an extensive mutagenesis study (Onrust et al., 1997) suggested that residues spanning the whole alpha 5 helix of the GTPase domain of Galpha subunit interacts with receptor. Moreover, a recent study indicated that the intramolecular interaction between the GTPase and helical domains (beta 4/alpha 3 and alpha G/alpha 4 loops) of Galpha subunit is important for receptor-mediated activation (Marsh et al., 1998). The series of tz chimeras retaining up to 143 C-terminal Galpha z residues essentially covered all the regions identified in the previous studies for receptor-mediated activation. The lack of DOR coupling with tz chimeras clearly indicated that the N-terminal half of Galpha subunit also contain essential elements for receptor coupling.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 6.   Alignment of the amino- and carboxyl-terminal regions of Galpha i2, Galpha t1, and Galpha z. Portions of the amino acid sequences of Galpha i2, Galpha t1, and Galpha z were extracted from their complete alignment using CLUSTAL X program (numbers in brackets indicate the positions of the residues; Jeanmougin et al., 1998). The strictly and homologously conserved amino acids are marked with asterisks and dots, respectively, at the bottom of the aligned sequences. A, inverted and underlined residues are essential and nonessential for receptor coupling, respectively (Conklin et al., 1993; Beck et al., 1997; Ho and Wong, 1997; Onrust et al., 1997). B, inverted and underlined residues are important and unrelated to effector interactions, respectively (Faurobert et al., 1993; Spickofsky et al., 1994; Grishina and Berlot, 1997).

Alignment of the amino acid sequences of Galpha i2, Galpha z, and Galpha t1 yielded useful information (Fig. 6). The most interesting point is that the N-terminal helix of Galpha t1 is 4 amino acids shorter than Galpha i2 and Galpha z, but the charge distribution of the aligned residues are reasonably similar. A fair prediction would be the length of the N-terminal helix determined the receptor coupling efficiency. The phenotypes of the mutants +4t/CG and -4z (Fig. 3) supported the importance of N-terminus of Galpha subunit in receptor coupling. Recent studies on the receptor coupling of Galpha q also support this notion. Deletion of the N-terminal six amino acids of Galpha q allowed the mutant to be activated by Gi-linked receptors (Kostenis et al., 1997). Alignment of the N-terminal sequences of various Galpha subunits showed that the first six residues were unique for Galpha q. Indeed, the sequence identities and lengths of the N-terminal helices of different Galpha subunits are very divergent and may be related to the peculiarities of the functions of each Galpha subunit. For example, the N-terminal residues of Galpha q are involved in membrane attachment (in addition to the palmitate attached) and phospholipase C activation (Hepler et al., 1996). In one of our previous studies (Ho and Wong, 1997), mutation of the two protein kinase C-phosphorylation sites at the N-terminus of Galpha z abolished its constitutive inhibitory effect on AC. Further studies on the roles of N-terminal residues of other Galpha subunits should provide more insights on their specific functions.

The crystal structures of trimeric G proteins (Wall et al., 1995; Lambright et al., 1996) provided clear evidence that the N-terminus of Galpha subunit is one of the major beta gamma -interacting sites. An early study of the interaction between Galpha o and beta gamma subunits suggested that the reduction of the length of the N-terminus of Galpha o by four residues (positions 7-10) diminishes its binding to beta gamma subunits (Denker et al., 1992). Preservation of the integrity of the N-terminal helix seems to be necessary for binding beta gamma subunits properly. In the present study, changes in the ability of the chimeras to associate with the beta gamma subunits might affect their coupling efficiencies to DOR. Moreover, it has been suggested that the N-terminal helix of Galpha subunit is sandwiched by Gbeta subunit and receptor (Wall et al., 1995; Lichtarge et al., 1996), and it may play a role in transmitting the conformational changes of ligand-bound receptor to the subsequent intra-and intermolecular conformational changes of G protein trimer. Additional studies are required to address these possibilities.

One of the well-characterized representatives in the Galpha i-subfamily in effector interaction is Galpha i2, which is probably the closest member to Galpha z. Berlot and coworkers have identified a region of 79 amino acids of Galpha i2, which was sufficient to convey the AC inhibition (Medina et al., 1996). The residues of Galpha i2 for effector regulation were resolved eventually using alanine mutagenesis by the same laboratory (Grishina and Berlot, 1997) and they are localized on two structural elements of Galpha i2, the Switch II region and the alpha 4/beta 6 loop. Our results coincided with the findings in Galpha i2, the amino acids 291 to 314 of Galpha z actually corresponded to alpha 4/beta 6 loop on the GTPase domain of Galpha z. The same loop structure (but not the same residues at the corresponding positions) in Galpha s, Galpha i2, and Galpha t1 has also been shown to be an effector interacting region (Berlot and Bourne, 1992; Spickofsky et al., 1994; Grishina and Berlot, 1997; Natochin et al., 1999). It is interesting that different categories of G protein-regulated effector enzymes have evolved to interact with the similar structural elements of various Galpha subunits. The alpha 4/beta 6 loop may be more than just a structural element bearing a single function. Using Galpha t1/Galpha i1 chimeras, Bae et al. (1997) showed that the area bounded by the alpha 4 helix and the alpha 4/beta 6 loop of Galpha i1 is important for the coupling of 5-HT1B receptor. Subsequent studies by the same group (Bae et al., 1999) demonstrated that two alpha 4 helical residues in Galpha i1 (Gln-304 and Glu-308) are critical determinants of receptor-G protein coupling. In the present study, the incorporation of the alpha 4/beta 6 loop of Galpha z in the Galpha t1 backbone (such as tz60 and tz143) did not allow coupling to DOR. Although the alpha 4 helix of Galpha z might be involved in receptor recognition, it alone was insufficient to support coupling to DOR.

We did not investigate further the importance of the Switch II region of Galpha z on AC inhibition because Galpha t1 and Galpha z have sequences identical with Galpha i2 at that region (Fig. 6) and so the corresponding region of Galpha t1 could provide essentially the same effector interacting residues. Inhibition of AC by Galpha z was not related to the N-terminal sequence of Galpha z because the constitutively active chimera tz60(RC) already exerted the inhibitory action (Fig. 4). The contribution of the variation of the G-1 GTP-binding region of Galpha z to the regulation of AC was only minimal (Fig. 2C). It implied that the slow GTP hydrolysis rate of Galpha z might not be related to the abilities of the chimeras to inhibit AC.

In conclusion, this report provides clear evidence that the N-terminal helix of Galpha z (and possibly that of Galpha i) is crucial for receptor-mediated activation. The length of the N-terminal helix is also critical for determining the efficiency of receptor coupling. The AC-inhibiting domains of Galpha z seem to be very similar to those of Galpha i2, including the alpha 4/beta 6 loop and Switch II region. Our results strongly suggested that Galpha z inhibited AC in a fashion similar to other inhibitory Galpha subunits.

    Acknowledgments

We thank Christopher Evans and Randall Reed for providing cDNAs of DOR and AC2, respectively.

    Footnotes

Received April 3, 2000; Accepted July 24, 2000

This work was supported in part by the Hong Kong Jockey Club and Grants HKUST 567/95M and 6096/98M from the Research Grants Council of Hong Kong to Y.H.W.

Send reprint requests to: Dr. Yung H. Wong, Department of Biochemistry and Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China. E-mail: boyung{at}ust.hk

    Abbreviations

AC, adenylyl cyclase; HEK, human embryonic kidney; DOR, delta -opioid receptor; AC2, type 2 adenylyl cyclase; PTX, pertussis toxin; DPDPE, [d-Pen2,5]enkephalin; PCR, polymerase chain reaction; MEM, Eagle's minimal essential medium.

    References
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References


0026-895X/00/050993-08$3.00/0
MOLECULAR PHARMACOLOGY, 58:993-1000 (2000).
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. E. Slessareva, H. Ma, K. M. Depree, L. A. Flood, H. Bae, T. M. Cabrera-Vera, H. E. Hamm, and S. G. Graber
Closely Related G-protein-coupled Receptors Use Multiple and Distinct Domains on G-protein {alpha}-Subunits for Selective Coupling
J. Biol. Chem., December 12, 2003; 278(50): 50530 - 50536.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
A. M.F. Liu, M. K.C. Ho, C. S.S. Wong, J. H.P. Chan, A. H.M. Pau, and Y. H. Wong
G{alpha} 16/z Chimeras Efficiently Link a Wide Range of G Protein-- Coupled Receptors to Calcium Mobilization
J Biomol Screen, January 1, 2003; 8(1): 39 - 49.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Uveges, D. Kowal, Y. Zhang, T. B. Spangler, J. Dunlop, S. Semus, and P. G. Jones
The Role of Transmembrane Helix 5 in Agonist Binding to the Human H3 Receptor
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 451 - 458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gilchrist, J. F. Vanhauwe, A. Li, T. O. Thomas, T. Voyno-Yasenetskaya, and H. E. Hamm
Galpha Minigenes Expressing C-terminal Peptides Serve as Specific Inhibitors of Thrombin-mediated Endothelial Activation
J. Biol. Chem., July 6, 2001; 276(28): 25672 - 25679.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, M. K.C.
Right arrow Articles by Wong, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, M. K.C.
Right arrow Articles by Wong, Y. H.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics